841 related articles for article (PubMed ID: 22895640)
21. Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma.
Choi D; Lee HW; Hur KY; Kim JJ; Park GS; Jang SH; Song YS; Jang KS; Paik SS
World J Gastroenterol; 2009 May; 15(18):2258-64. PubMed ID: 19437567
[TBL] [Abstract][Full Text] [Related]
22. Expression of cancer stem cell marker during 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.
Lim W; Choi H; Kim J; Kim S; Jeon S; Ni K; Song SY; Oh HK; Im Y; Lee G; Lee JY; Moon YL; You JW; Kim O
J Mol Histol; 2014 Dec; 45(6):653-63. PubMed ID: 25001207
[TBL] [Abstract][Full Text] [Related]
23. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of microRna-200c in CD44+CD133+ CSCS inhibits the cellular migratory and invasion as well as tumorigenicity in mice.
Dou J; He XF; Cao WH; Zhao FS; Wang XY; Liu YR; Wang J
Cell Mol Biol (Noisy-le-grand); 2013 Oct; Suppl 59():OL1861-8. PubMed ID: 24120113
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy.
Mizukami T; Kamachi H; Mitsuhashi T; Tsuruga Y; Hatanaka Y; Kamiyama T; Matsuno Y; Taketomi A
BMC Cancer; 2014 Sep; 14():687. PubMed ID: 25240521
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells.
Sahlberg SH; Spiegelberg D; Glimelius B; Stenerlöw B; Nestor M
PLoS One; 2014; 9(4):e94621. PubMed ID: 24760019
[TBL] [Abstract][Full Text] [Related]
27. A Validation Study of CD133 as a Reliable Marker for Identification of Colorectal Cancer Stem-Like Cells.
You CZ; Xu H; Zhao FS; Dou J
Bull Exp Biol Med; 2024 Jan; 176(3):369-375. PubMed ID: 38340198
[TBL] [Abstract][Full Text] [Related]
28. Detection of minor subpopulations of colorectal adenocarcinoma cells expressing cancer stem cell markers.
Gisina AM; Lupatov AY; Karalkin PA; Mainovskaya OA; Petrov LO; Sidorov DV; Yarygin VN; Yarygin KN
Bull Exp Biol Med; 2011 Jun; 151(2):234-8. PubMed ID: 22238758
[TBL] [Abstract][Full Text] [Related]
29. Characterization and propagation of tumor initiating cells derived from colorectal liver metastases: trials, tribulations and a cautionary note.
James MI; Howells LM; Karmokar A; Higgins JA; Greaves P; Cai H; Dennison A; Metcalfe M; Garcea G; Lloyd DM; Berry DP; Steward WP; Brown K
PLoS One; 2015; 10(2):e0117776. PubMed ID: 25658706
[TBL] [Abstract][Full Text] [Related]
30. Identification of a subpopulation of long-term tumor-initiating cells in colon cancer.
Peng L; Xiong Y; Wang R; Xiang L; Zhou H; Gu H
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32729895
[TBL] [Abstract][Full Text] [Related]
31. Expression of gastrin precursors by CD133-positive colorectal cancer cells is crucial for tumour growth.
Ferrand A; Sandrin MS; Shulkes A; Baldwin GS
Biochim Biophys Acta; 2009 Mar; 1793(3):477-88. PubMed ID: 19321126
[TBL] [Abstract][Full Text] [Related]
32. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
[TBL] [Abstract][Full Text] [Related]
33. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
[TBL] [Abstract][Full Text] [Related]
34. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G
J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409
[TBL] [Abstract][Full Text] [Related]
35. Effects of metformin on CD133+ colorectal cancer cells in diabetic patients.
Zhang Y; Guan M; Zheng Z; Zhang Q; Gao F; Xue Y
PLoS One; 2013; 8(11):e81264. PubMed ID: 24278407
[TBL] [Abstract][Full Text] [Related]
36. Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.
Zhou JY; Chen M; Ma L; Wang X; Chen YG; Liu SL
Oncotarget; 2016 Feb; 7(7):7657-66. PubMed ID: 26840024
[TBL] [Abstract][Full Text] [Related]
37. Detection of putative stem cell markers, CD44/CD133, in primary and lymph node metastases in head and neck squamous cell carcinomas. A preliminary immunohistochemical and in vitro study.
Mannelli G; Magnelli L; Deganello A; Busoni M; Meccariello G; Parrinello G; Gallo O
Clin Otolaryngol; 2015 Aug; 40(4):312-20. PubMed ID: 25641707
[TBL] [Abstract][Full Text] [Related]
38. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
Calcagno AM; Salcido CD; Gillet JP; Wu CP; Fostel JM; Mumau MD; Gottesman MM; Varticovski L; Ambudkar SV
J Natl Cancer Inst; 2010 Nov; 102(21):1637-52. PubMed ID: 20935265
[TBL] [Abstract][Full Text] [Related]
39. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
[TBL] [Abstract][Full Text] [Related]
40. Krüppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells.
Leng Z; Tao K; Xia Q; Tan J; Yue Z; Chen J; Xi H; Li J; Zheng H
PLoS One; 2013; 8(2):e56082. PubMed ID: 23418515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]